2014-2018 US Point-of-Care Hematology and Flow Cytometry Markets: Physician Offices, Emergency Rooms, Operating Suites, ICUs/CCUs, Cancer Clinics, Ambulatory Care Centers, Surgery Centers, Nursing Homes, Birth Centers-Supplier Shares, Country Forecasts, Emerging Technologies, Competitive Strategies. This new 238-page report from Venture Planning Group contains 38 tables, and provides a comprehensive analysis of the POC hematology and flow cytometry market, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies for the global POC hematology and flow cytometry market. Research Beam Model: Research Beam Product ID: 174821 3600 USD New
2014-2018 US Point-of-Care Hematology and Flow Cytometry Markets: Physician Offices, Emergency Rooms, Operating Suites, ICUs/CCUs, Cancer Clinics, Ambulatory Care Centers, Surgery Centers, Nursing Homes, Birth Centers-Supplier Shares, Country Forecasts, Emerging Technologies, Competitive Strategies.

Toll Free : +1 (800)910-6452

 
 
PURCHASE OPTIONS
 

2014-2018 US Point-of-Care Hematology and Flow Cytometry Markets: Physician Offices, Emergency Rooms, Operating Suites, ICUs/CCUs, Cancer Clinics, Ambulatory Care Centers, Surgery Centers, Nursing Homes, Birth Centers-Supplier Shares, Country Forecasts, Emerging Technologies, Competitive Strategies.

 
  • Category : Diagnostic and Biotech
  • Published On : November  2014
  • Pages : 238
 
 

2014-2018 US Point-of-Care Hematology and Flow Cytometry Markets: Physician Offices, Emergency Rooms, Operating Suites, ICUs/CCUs, Cancer Clinics, Ambulatory Care Centers, Surgery Centers, Nursing Homes, Birth Centers-Supplier Shares, Country Forecasts, Emerging Technologies, Competitive Strategies.



This new 238-page report from Venture Planning Group contains 38 tables, and provides a comprehensive analysis of the POC hematology and flow cytometry market, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies for the global POC hematology and flow cytometry market.

Rationale

The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient.

Market Segmentation Analysis.



Review of nine POC market segments, including their dynamics, trends, structure, size, growth and major suppliers.



Five-year test volume and reagent sales forecasts for hematology and flow cytometry procedures by market segment:



Physician Offices/Group Practices

Emergency Rooms

Operating/Recovery Suites

ICUs/CCUs

Cancer Clinics

Ambulatory Care Centers

Surgery Centers

Nursing Homes

Birth Centers

Sales and Market Share Analysis

Sales and market shares of major hematology and flow cytometry reagent and instrument suppliers.



Instrument Placements and Installed Base

The report provides estimates of annual placements and total installed base for major hematology and flow cytometry analyzers.

Current and Emerging Products

Analysis of hematology and flow cytometry procedures performed in POC testing locations.

Review of leading hematology and flow cytometry analyzers, both currently marketed and those in development, including their operating characteristics, features and selling prices.



Technology Review

Emerging technologies and their applications for POC testing.

Comprehensive listings of companies developing or marketing hematology and flow cytometry testing technologies and products, by assay.



Competitive Assessments

Assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, joint ventures, and new products in R&D.

Strategic Recommendations



Specific opportunities for new hematology and flow cytometry instruments and reagent systems with potentially significant market appeal during the next five years.

Design criteria for POC testing products.

Alternative business expansion strategies.

Potential market entry barriers and risks.



Methodology

This report is based on a combination of primary and secondary sources of information, including review of the latest technical and business publications, manufacturer product literature, industry analyst reports, and Venture Planning Group's proprietary data files.